<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39090598</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Acute and long COVID-19 symptoms and associated factors in the omicron-dominant period: a nationwide survey via the online platform Wenjuanxing in China.</ArticleTitle><Pagination><StartPage>2086</StartPage><MedlinePgn>2086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-19510-w</ELocationID><Abstract><AbstractText Label="BACKGROUNDS" NlmCategory="BACKGROUND">To our knowledge, there is no available nationwide data on omicron symptom patterns in China mainland. We aim to determine the acute and long COVID-19 symptoms in the omicron-dominant period and to evaluate its association with risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We designed a cross-sectional nationwide study and data about self-reported symptoms were collected by an online platform named Wenjuanxing. Eligible participants were aged 25-65 years and were symptomatic. In this study, the ratios of the number of people of different ages and genders were weighted by the data from the Seventh National Census (2020 years), and validated by a published nationwide representative study through comparing smoking rates. Descriptive indicators were calculated for demographic characteristics, diagnosis ways, and duration time, acute symptoms, hospitalization, severity and long COVID-19 symptoms. And, the associations between risk factors and acute and long COVID-19 symptoms were analyzed by multivariable logistic regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 32,528 individuals diagnosed as COVID-19 infection from October 1, 2022 to February 21, 2023 were included. The first three acute symptoms of COVID-19 infection were fever (69.90%), headache (62.63%), and sore throat (54.29%), respectively. The hospitalization rate within 7 days was 3.07% and symptoms disappearance rate within 21 days was 68.84%, respectively. Among 3983 COVID-19 patients with 3 months or more time difference between first infection and participation into the study, the long COVID-19 rate was 19.68% and the primary symptoms were muscle weakness (19.39%), headache (17.98%) and smell/taste disorder (15.18%). Age groups, smoking, marriage status and vaccination were risk factors for numbers of acute phase symptoms and long COVID-19 symptoms. Lastly, female and current smokers also showed more numbers of symptoms during acute infection period.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In Chinese mainland, our respondent indicated that current smokers and women were associated with acute COVID-19 symptoms, which should be treated with caution due to the lack of representative.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yinghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>China Health Education Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhenxiao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Anqi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xinmei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinxuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xiaowen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Qingqing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. danxiao@263.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 symptoms patterns</Keyword><Keyword MajorTopicYN="N">China mainland</Keyword><Keyword MajorTopicYN="N">Female</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39090598</ArticleId><ArticleId IdType="pmc">PMC11295386</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-19510-w</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-19510-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus Disease WHO. Coronavirus (COVID-19) Dashboard. [https://covid19.who.int/].</Citation></Reference><Reference><Citation>Tracking SARS-CoV-2 variants. [https:/www.who.int/activities/tracking-SARS-CoV-2-variants.].</Citation></Reference><Reference><Citation>COVID-19. Variants of the Virus. [https://www.cdc.gov/coronavirus/2019-ncov/variants/variant.html].</Citation></Reference><Reference><Citation>Taylor CA, Patel K, Pham H, Whitaker M, Anglin O, Kambhampati AK, Milucky J, Chai SJ, Kirley PD, Alden NB, et al. Severity of Disease among adults hospitalized with laboratory-confirmed COVID-19 before and during the period of SARS-CoV-2 B.1.617.2 (Delta) predominance - COVID-NET, 14 States, January-August 2021. MMWR Morbidity Mortal Wkly Rep. 2021;70(43):1513&#x2013;9.10.15585/mmwr.mm7043e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7043e1</ArticleId><ArticleId IdType="pmc">PMC8553023</ArticleId><ArticleId IdType="pubmed">34710076</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM, Cobb S, Graff P, Hidalgo P, Panaggio MJ, et al. Trends in Disease Severity and Health Care utilization during the early omicron variant period compared with previous SARS-CoV-2 High Transmission periods - United States, December 2020-January 2022. MMWR Morbidity Mortal Wkly Rep. 2022;71(4):146&#x2013;52.10.15585/mmwr.mm7104e4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7104e4</ArticleId><ArticleId IdType="pmc">PMC9351529</ArticleId><ArticleId IdType="pubmed">35085225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, Ekka-Zohar A, Ben David SS, Lerner U, Bivas-Benita M, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ (Clinical Res ed). 2023;380:e072529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Cox RJ, Langeland N. Long COVID: a growing problem in need of intervention. Cell Rep Med. 2022;3(3):100552. 10.1016/j.xcrm.2022.100552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100552</ArticleId><ArticleId IdType="pmc">PMC8841141</ArticleId><ArticleId IdType="pubmed">35474749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post-coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a Meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>[https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic]].</Citation></Reference><Reference><Citation>[https://covid.cdc.gov/covid-data-tracker/#trends_weeklydeaths_select_00].</Citation></Reference><Reference><Citation>Corona Virus Disease. 2019 [https://www.chinacdc.cn/jkzt/crb/zl/szkb-11803/]].</Citation></Reference><Reference><Citation>Classification of omicron (B.1.1.529). SARS-CoV-2 variant of concern. [https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern]]</Citation></Reference><Reference><Citation>Tracking of variants. [https://www.gisaid.org/hcov19-variants/].</Citation></Reference><Reference><Citation>Jassat WKS, Mudara C et al. Clinical severity of COVID-19 patients admitted to hospitals in Gauteng, South Africa during the omicron-dominant fourth wave. medRxiv: the preprint server for health sciences 2021.</Citation></Reference><Reference><Citation>Davies MA, Kassanjee R, Rosseau P, Morden E, Johnson L, Solomon W, Hsiao NY, Hussey H, Meintjes G, Paleker M et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. medRxiv: the preprint server for health sciences 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115442</ArticleId><ArticleId IdType="pubmed">35411997</ArticleId></ArticleIdList></Reference><Reference><Citation>Houhamdi L, Gautret P, Hoang VT, Fournier PE, Colson P, Raoult D. Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. J Med Virol. 2022;94(5):2290&#x2013;5. 10.1002/jmv.27613</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27613</ArticleId><ArticleId IdType="pmc">PMC9015264</ArticleId><ArticleId IdType="pubmed">35060146</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron Wave compared with previous waves. JAMA. 2022;327(6):583&#x2013;4. 10.1001/jama.2021.24868</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24868</ArticleId><ArticleId IdType="pmc">PMC8719272</ArticleId><ArticleId IdType="pubmed">34967859</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet (London England). 2022;399(10335):1618&#x2013;24. 10.1016/S0140-6736(22)00327-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet (London England). 2022;399(10332):1303&#x2013;12. 10.1016/S0140-6736(22)00462-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, Amoako DG, Everatt J, Bhiman JN, Scheepers C, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet (London England). 2022;399(10323):437&#x2013;46. 10.1016/S0140-6736(22)00017-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00017-4</ArticleId><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk for COVID-19 Infection, Hospitalization, and Death By Age Group. [https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html]]</Citation></Reference><Reference><Citation>Prevalence of ongoing symptoms following. coronavirus (COVID-19) infection in the UK. [https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19/infectionintheuk/3march2022]</Citation></Reference><Reference><Citation>Bowyer RCE, Huggins C, Toms R, Shaw RJ, Hou B, Thompson EJ, Kwong ASF, Williams DM, Kibble M, Ploubidis GB, et al. Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies. Eur J Epidemiol. 2023;38(2):199&#x2013;210. 10.1007/s10654-022-00962-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00962-6</ArticleId><ArticleId IdType="pmc">PMC9860244</ArticleId><ArticleId IdType="pubmed">36680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399&#x2013;401. 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ (Clinical Res ed). 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ (Clinical Res ed). 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Res ed). 2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet (London England). 2021;398(10302):747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw open. 2021;4(2):e210830. 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, O&#x2019;Hara M, Suett J, Dahmash D, Bugaeva P et al. Characterising long COVID: a living systematic review. BMJ Global Health 2021, 6(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, et al. 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respiratory Med. 2021;9(7):3&#x2013;month.10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Ling Y, Jiang M, Tan Y, Wei D, Jiang L, Yu S, Jiang F, Wang S, Dai Y et al. Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland. Front Med 2023:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064619</ArticleId><ArticleId IdType="pubmed">37000349</ArticleId></ArticleIdList></Reference><Reference><Citation>Notice on Issuing the. Overall Plan for Implementing Class B Management for COVID- 19 Infection. [http://www.nhc.gov.cn]].</Citation></Reference><Reference><Citation>Notice on Further Optimizing Measures for the Prevention and Control of COVID-19. Epidemic and Scientifically and Precisely Carrying out Prevention and Control Work. [http://www.nhc.gov.cn]].</Citation></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case defnition of post-COVID. -19 condition by a Delphi consensus. [https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-defnition-2021.1]].</Citation></Reference><Reference><Citation>Breslin KM, O&#x2019;Donoghue L, Saunders KJ. An investigation into the validity of self-reported classification of refractive error. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2014;34(3):346&#x2013;52.10.1111/opo.12113</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/opo.12113</ArticleId><ArticleId IdType="pubmed">24345090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ (Clinical Res ed). 2020;368:m1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangia C, Russo A, Civitelli S, Gianicolo EAL. Sex/gender differences in COVID-19 lethality: what the data say, and do not say. Epidemiol Prev. 2020;44(5&#x2013;6 Suppl 2):400&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33412835</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo PA, Manson JE, Joffe H. Sex and gender differences in Health: what the COVID-19 pandemic can teach us. Ann Intern Med. 2020;173(5):385&#x2013;6. 10.7326/M20-1941</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1941</ArticleId><ArticleId IdType="pmc">PMC7249504</ArticleId><ArticleId IdType="pubmed">32384135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MK, Lee B, Choi YY, Um J, Lee KS, Sung HK, Kim Y, Park JS, Lee M, Jang HC, et al. Clinical characteristics of 40 patients infected with the SARS-CoV-2 Omicron variant in Korea. J Korean Med Sci. 2022;37(3):e31. 10.3346/jkms.2022.37.e31</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e31</ArticleId><ArticleId IdType="pmc">PMC8763884</ArticleId><ArticleId IdType="pubmed">35040299</ArticleId></ArticleIdList></Reference><Reference><Citation>Omicron spreads but severe cases remain low in South Africa. [https://www.afro.who.int/news omicron-spreads-severe-cases-remain-low-south-africa omicron-spreads-severe-cases-remain-low-south-africa ].</Citation></Reference><Reference><Citation>Torjesen I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ (Clinical Res ed). 2021;375:n2943.</Citation><ArticleIdList><ArticleId IdType="pubmed">34845008</ArticleId></ArticleIdList></Reference><Reference><Citation>Transcription of the Press Conference of the State Council Joint Prevention and, Mechanism C. [http://www.nhc.gov.cn]].</Citation></Reference><Reference><Citation>Liu K, He M, Zhuang Z, He D, Li H. Unexpected positive correlation between human development index and risk of infections and deaths of COVID-19 in Italy. One Health (Amsterdam Netherlands). 2020;10:100174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522624</ArticleId><ArticleId IdType="pubmed">33015305</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, McCarthy CG, Falcon CJ, Schoenfeld AJ, Arbour KC, et al. COVID-19 in patients with lung cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2020;31(10):1386&#x2013;96.10.1016/j.annonc.2020.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7297689</ArticleId><ArticleId IdType="pubmed">32561401</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Long X, Zhang Q, Fang X, Li N, Fedorova B, Hu S, Li J, Xiong N, Lin Z. Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging. J Intern Med. 2021;289(4):574&#x2013;83. 10.1111/joim.13190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13190</ArticleId><ArticleId IdType="pmc">PMC7753648</ArticleId><ArticleId IdType="pubmed">33270312</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, von Ende A, Tan PS, Sallis HM, Lindson N, Coupland CAC, Munaf&#xf2; MR, Aveyard P, Hippisley-Cox J, Hopewell JC. Smoking and COVID-19 outcomes: an observational and mendelian randomisation study using the UK Biobank cohort. Thorax. 2022;77(1):65&#x2013;73. 10.1136/thoraxjnl-2021-217080</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217080</ArticleId><ArticleId IdType="pmc">PMC8483921</ArticleId><ArticleId IdType="pubmed">34580193</ArticleId></ArticleIdList></Reference><Reference><Citation>Benowitz NL, Goniewicz ML, Halpern-Felsher B, Krishnan-Sarin S, Ling PM, O&#x2019;Connor RJ, Pentz MA, Robertson RM, Bhatnagar A. Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research. Lancet Respiratory Med. 2022;10(9):900&#x2013;15.10.1016/S2213-2600(22)00182-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00182-5</ArticleId><ArticleId IdType="pmc">PMC9381032</ArticleId><ArticleId IdType="pubmed">35985357</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyunoya T, Mebratu Y, Contreras A, Delgado M, Chand HS, Tesfaigzi Y. Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. Am J Respir Cell Mol Biol. 2014;50(3):471&#x2013;82. 10.1165/rcmb.2013-0348TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0348TR</ArticleId><ArticleId IdType="pmc">PMC4068939</ArticleId><ArticleId IdType="pubmed">24111585</ArticleId></ArticleIdList></Reference><Reference><Citation>Self-reported. Long COVID after infection with the Omicron variant in the UK.</Citation></Reference><Reference><Citation>Gottlieb M, Wang R, Yu H, Spatz ES, Montoy JC, Rodriguez R, Chang AM, Elmore JG, Hannikainen PA, Hill M et al. Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, Das K, G A, Venkateshan M, Mishra B, Patro BK, Mohapatra PR, Subba SH. Characteristics and predictors of long COVID among diagnosed cases of COVID-19. PLoS ONE. 2022;17(12):e0278825. 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Roy P, Ravichandran M, Mandal S, Pal D, Das K, Gajjala A, Venkateshan M, Mishra B, et al. Long COVID following Omicron wave in Eastern India-A retrospective cohort study. J Med Virol. 2023;95(1):e28214. 10.1002/jmv.28214</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;7. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long COVID: an International Survey of people with lived experience of long COVID. Vaccines 2022, 10(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;62. 10.1016/j.bbi.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, Horn C, Vanshylla K, Cristanziano VD, Osebold L, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Europe. 2021;6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, S&#xe6;vik M, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, Christiansen CF, Thomsen RW, Potteg&#xe5;rd A. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373&#x2013;82. 10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, Augello M, Mondatore D, Allegrini M, Cona A et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28(4):611.e619-611.e616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;e895820. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, Ward H, Elliott P. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M, Mercad&#xe9;-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, Rathod-Mistry T, Kostka K, Man WY, Delmestri A, et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respiratory Med. 2024;12(3):225&#x2013;36.10.1016/S2213-2600(23)00414-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball HL. Conducting online surveys. J Hum Lactation: Official J Int Lactation Consultant Association. 2019;35(3):413&#x2013;7.10.1177/0890334419848734</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0890334419848734</ArticleId><ArticleId IdType="pubmed">31084575</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma AK, Gupta R, Baig VN, Singh VT, Chakraborty S, Sunda JP, Dhakar P, Sharma SP, Panwar RB, Katoch VM. Educational status and COVID-19 related outcomes in India: hospital-based cross-sectional study. BMJ open. 2022;12(2):e055403. 10.1136/bmjopen-2021-055403</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055403</ArticleId><ArticleId IdType="pmc">PMC8882634</ArticleId><ArticleId IdType="pubmed">35217540</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SL, Pereira RHM, Prete CA Jr., Zarebski AE, Emanuel L, Alves PJH, Peixoto PS, Braga CKV, de Souza Santos AA, de Souza WM et al. Higher risk of death from COVID-19 in low-income and non-white populations of S&#xe3;o Paulo, Brazil. BMJ Global Health 2021, 6(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094342</ArticleId><ArticleId IdType="pubmed">33926892</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar KMJ, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, Brown S, Pressman AR. Disparities in outcomes among COVID-19 patients in a large Health Care System in California. Health Aff. 2020;39(7):1253&#x2013;62.10.1377/hlthaff.2020.00598</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2020.00598</ArticleId><ArticleId IdType="pubmed">32437224</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh TK, Choi JW, Song IA. Socioeconomic disparity and the risk of contracting COVID-19 in South Korea: an NHIS-COVID-19 database cohort study. BMC Public Health. 2021;21(1):144. 10.1186/s12889-021-10207-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10207-y</ArticleId><ArticleId IdType="pmc">PMC7809637</ArticleId><ArticleId IdType="pubmed">33451306</ArticleId></ArticleIdList></Reference><Reference><Citation>Salyer SJ, Maeda J, Sembuche S, Kebede Y, Tshangela A, Moussif M, Ihekweazu C, Mayet N, Abate E, Ouma AO, et al. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study. Lancet (London England). 2021;397(10281):1265&#x2013;75. 10.1016/S0140-6736(21)00632-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00632-2</ArticleId><ArticleId IdType="pmc">PMC8046510</ArticleId><ArticleId IdType="pubmed">33773118</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede LE, Walker RJ. Structural racism, Social Risk factors, and Covid-19 - a dangerous convergence for Black americans. N Engl J Med. 2020;383(12):e77. 10.1056/NEJMp2023616</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2023616</ArticleId><ArticleId IdType="pmc">PMC7747672</ArticleId><ArticleId IdType="pubmed">32706952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavizzo-Mourey RJ, Besser RE, Williams DR. Understanding and Mitigating Health inequities - Past, current, and future directions. N Engl J Med. 2021;384(18):1681&#x2013;4. 10.1056/NEJMp2008628</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2008628</ArticleId><ArticleId IdType="pubmed">33951376</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeisler M, Wiley JF, Czeisler CA, Rajaratnam SMW, Howard ME. Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic. Epidemiol Psychiatric Sci. 2021;30:e45.10.1017/S204579602100038X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S204579602100038X</ArticleId><ArticleId IdType="pmc">PMC8207539</ArticleId><ArticleId IdType="pubmed">34036933</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140&#x2013;5. 10.1038/s41586-020-2918-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2918-0</ArticleId><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. 10.1016/j.arr.2020.101205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>National novel coronavirus infection situation, China. 2023. https://www.chinacdc.cn/jkzt/crb/zl/szkb-11803/jszl-13141/202304/t20230429-265709. Accessed 29 Apr 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>